Lymphedema (LE) is a well‐known postoperative complication after axillary node dissection
(ALND). Although, sentinel lymph node dissection (SLND) involves more focused surgery …

Background Complementary and alternative medicine (CAM) use is common among cancer
patients. This paper reviews the use of CAM in a series of patients with locally advanced …

Background Most gastric cancer patients present with advanced stage disease precluding
curative surgical treatment. These patients may be considered for palliative resection or …

Objective To describe the processes of care for gastric cancer in Ontario and identify areas
in which care and possibly survival can be improved. Summary Background Data Survival in …

Importance There is growing interest in reducing the variations and deficiencies in the
multidisciplinary management of gastric cancer. Objective To define optimal treatment strategies …

Background Stage IV gastric cancer is lethal, and little population-based research on prognostic
factors has been performed in low-incidence countries. Therefore, we investigated the …

Background Relief of symptoms should be the primary focus of palliative treatment as defined
by the World Health Organization. Evaluating the effectiveness of palliative interventions …

Background Malignant bowel obstruction (MBO) is a feature of the clinical course of 10–28%
of colorectal cancer (CRC) patients and is associated with a poor prognosis. Recent …

Background Gastric perforation is a rare presentation of gastric cancer and is thought to be
a predictor of advanced disease and, thus, poor prognosis. Guidelines do not exist for the …

Aldehyde dehydrogenase 1A3 (ALDH1A3) is a cancer stem cell marker that promotes
metastasis. Triple‐negative breast cancer (TNBC) progression has been linked to ALDH1A3‐…